HVS Animal Health

Sheep

The aim of the trial on Liqui Thrive Sheep was to assess the biological and financial impact of dosing with Liqui Thrive Sheep on a hill flock, with particular reference to fertility, lamb performance and economic outcome.

As a pre-condition of the trial, S.A.C. required a commercial flock of over 600 ewes that were well managed and situated on a farm with non clinical or sub clinical Copper, Cobalt or Selenium deficiencies. At the outset of the trial, and before the Liqui Thrive Sheep had been given, blood samples were taken from 20 of the Control ewes. As a majority of them were below the normal range (9.4-23 mol/l) for copper, all the ewes in the flock were given a subqutaneous copper injection seven weeks before lambing.

By this stage the reproductive effect of Liqui Thrive had already occurred. It could be argued that this blanket treatment of all ewes prevented any copper related effects of Liqui Thrive Sheep occurring after mid-pregnancy and it is therefore impossible to say whether a larger biological of financial difference over the whole trial would have occurred if the specific Copper treatment i.e. Cujec, had not been given.

Dosing Programme

Ewes

Treated (ET)
Control (EC)
4 weeks pre mating
20 mls
nil
7 weeks pre lambing
Copper Injection
Copper Injection
4 weeks pre lambing
20mls
nil
All other treatments were the same

Lambs

Treated (LT)
Control (LC)
LT/ET
LT/EC
LC/ET
LC/EC
At marking
(average age – 6 weeks)
5mls
5mls
nil
nil
All other treatments were the same

Lambing Dates
Results for Ewe Performance

There were significant differences in mean lambing dates between treatments, with treated ewes advancing lambing and peaking at 12 days after the first lamb was born, compared to 15 days for untreated ewes (sed 0.73, p<0.005). Compared to untreated ewes, a higher proportion of treated ewes conceived in days 1-8 (x2=6.8, p<0.001) with 80% conceiving in the first cycle (x2=5.4, p<0.025).

Results for Lamb Preference

Treated Ewes
Untreated Ewes
Lambs Born
per ewe mated
1.389
1.301
Lambs reared
per ewe mated
1.442
1.386
Lambs lost
per ewe lambing
0.057
0.078
% Barren ewes
6.5
8.1

Throughout lactation and at weaning, untreated lambs (LC/ET) from treated ewes were heavier (32.72kg) than untreated lambs (LC/EC) from untreated ewes (31.81kg) and were marginally heavier than lambs treated at marking (LT/EC) .

Mule ewe lambs from treated ewes (LC/ET) sold on average at £4.52 per lamb more than their counterparts with 67% being sold for breeding compared to 51% from untreated ewes (LC/EC).

Mule ewe lambs treated at marking from untreated ewes (LT/EC) sold for an additional £5.67. However, the lambs from treated ewes produced a higher value per ewe, due to greater lambing percentages and lower losses.

Economic Value Per Ewe

Ewe Treatment
Treated (ET)
Untreated (EC)
Lamb Treatment
Treated
LT/ET
Untreated
LC/ET
Treated
LT/EC
Untreated
LC/EC
Value per Lamb
£44.67
£44.79
£45.37
£43.35
Value per Ewe
£60.88
£61.05
£57.80
£55.20
Diff compared to no treatment (EC/LC)
£5.86
£5.85
£2.60

Discussion & Conclusion

The results demonstrate a clear impact of Liqui Thrive Sheep on fertility through a tightening of the lambing period, indicating better conception. This reproductive effect is supported by increased litter size and reduced barrenness seen in treated ewes. The impact on lamb growth and financial value cannot be related to fertility. It is the combination of impacts on ewe production, lamb survival, growth and financial value that together reinforce the view that there is a biological impact from the product. The financial values per ewe, which draw together all these factors, very much meets the claims made for the product.

S.A.C. Liqui Thrive Sheep Trial – Update
Financial measurement of the benefit, in terms of higher price per lamb sold, or profit per ewes treated, will vary from year to year and from flock to flock, dependent on conditions prevailing at the time of sale.

What does not vary is the extent of benefit reported in the trial and experienced by thousands of farmers over the past eight years.

Ewes:
Better conception
Tighter lambing
Less barrens
Lambs:
More lambs
Less losses
Better growth rate
Higher sale price
S.A.C. State: “The financial values per ewe, which draw together all these factors, very much meet the claims for this product.”
Whether the financial benefit is measured in increased profit, or the difference between selling and not selling, will depend on the state of the market. Either way, the return on cost is substantial and worthwhile.
Trial conducted by:
Robin Mair BSc (Agric.) Hons, Edinburgh,
Advistory Service, S.A.C. Sterling
Tony Waterhouse BSc (Hons), PhD, Grossland & Ruminent
Service Dept.,

with the co-operation of:
J & E Aitken and Son of Overton Farm, Fintry, Sterlingshire.

Our Offices

  • HVS Animal Health
  • 27 Inch Abbey Road,
  • Downpatrick,
  • Co Down,
  • Northern Ireland.
  • BT30 9AT

Distributor For

  • Agri Lloyd, England
  • Trouw Nutrition International (Irish distributors for Trouw Nutrition International for Optimin Minerals)
  • Indian Herbs, Saharanpur, India
  • Hovet | Homoeopathic Veteninary Products, UK

Contact Us

  • Freephone | 0800 0345 660
  • Tel | 028 4461 2678
  • Fax | 028 4461 4801
  • Mobile | 078 6028 1220
  • E-mail | info@hvsanimalhealth.com